Indications and uses
acid indigestion heartburn sour stomach upset stomach from overindulgence in food or drink
Stomachin Antacid
- Manufacturer
- Chang Kuo Chou Pharmaceutical Co. Ltd.
- Effective date
- 2011-08-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:29:17
Label at a glance#
ProductStomachin Antacid
Active ingredientMagnesium carbonate, Sodium bicarbonate
Label structure11 sections
Dosage and administration
TAke two capsules with water 3 times a day
Label contents#
Full prescribing information#
Active ingredients (in each capsule) Purpose
Magnesium carbonate 58mg ................... Antacid
Sodium bicarbonate 809mg .................... Antacid
Uses
- acid indigestion
- heartburn
- sour stomach
- upset stomach from overindulgence in food or drink
Stop use and as a doctor if
- symptoms persit or worsen
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant of breast feeding, ask a health professional before use.
INDICATIONS & USAGE SECTION
Antacid
Directions
TAke two capsules with water 3 times a day
Do not use
more than 6 capsules in a 24-hour period, or use the maximum dosage of this product for more than 2 weeks, expect under the advice and supervision of a physician.
Inactive ingredients
clove, hydroxypropyl cellulose, licorice, menthol, rhubarb
Ask a doctor or pharmacist before use if you are
- presently taking a prescription drug. Antacid may interact with certain prescription drugs
- on magnesium or sodium restrict diet.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BICARBONATE ION Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20220121 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43337-9328-6 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c1b2-8e05-e053-dbdaa90a074a | "Drug Facts" |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43337-9328-6 | Stomachin Antacid | 2 in 1 BOX | CAPSULE | 2 | 1 | |
| 43337-9328-6 | Stomachin Antacid | 20 in 1 BLISTER PACK | CAPSULE | 20 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43337-9328 | STOMACHIN ANTACID (MAGNESIUM CARBONATE AND SODIUM BICARBONATE) CAPSULE [CHANG KUO CHOU PHARMACEUTICAL CO. LTD.] | 1 | Legacy NDC, 2 package rows | 20110823_c670b97e-98cc-4558-998e-039be5ffd509.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Magnesium carbonate | ACTIVE INGREDIENT | 0E53J927NA | 1 | |
| Sodium bicarbonate | ACTIVE INGREDIENT | 8MDF5V39QO | 1 | |
| Bicarbonate ion | ACTIVE MOIETY | HN1ZRA3Q20 | 1 | |
| Carbonate ion | ACTIVE MOIETY | 7UJQ5OPE7D | 1 | |
| Clove | INACTIVE INGREDIENT | K48IKT5321 | 1 | |
| Hydroxypropyl Cellulose | INACTIVE INGREDIENT | RFW2ET671P | 1 | |
| Licorice | INACTIVE INGREDIENT | 61ZBX54883 | 1 | |
| Menthol | INACTIVE INGREDIENT | L7T10EIP3A | 1 | |
| Rhubarb | INACTIVE INGREDIENT | G280W4MW6E | 1 |
Products#
Every source-derived product name is available through these pages.
- Stomachin Antacid
- Magnesium carbonate and Sodium bicarbonate
- Magnesium carbonate
- Magnesium cation
- Carbonate ion
- Sodium bicarbonate
- Sodium cation
- Bicarbonate ion
- Clove
- Hydroxypropyl Cellulose
- Licorice
- Menthol
- Rhubarb
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43337-9328 | 43337-9328-6 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Magnesium carbonate | 0E53J927NA | ACTIB |
| Sodium bicarbonate | 8MDF5V39QO | ACTIB |
| Clove | K48IKT5321 | IACT |
| Hydroxypropyl Cellulose | RFW2ET671P | IACT |
| Licorice | 61ZBX54883 | IACT |
| Menthol | L7T10EIP3A | IACT |
| Rhubarb | G280W4MW6E | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 187.6 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 39.2 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION, CONCENTRATE / ORAL | 0.5 mg/1ml | ||
| Menthol | MENTHOL | L7T10EIP3A | SUSPENSION / ORAL | 1 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | POWDER, FOR SOLUTION / ORAL | NA | ||
| Menthol | MENTHOL | L7T10EIP3A | CREAM / TOPICAL | 0.1 %w/w | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, FILM COATED / ORAL | 131.67 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOZENGE / ORAL | 500 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | GUM, CHEWING / BUCCAL | 89 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | DROPS / NASAL | 40.32 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | SUSPENSION / ORAL | 100 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | PASTE, DENTIFRICE / DENTAL | 4.7 %w/w | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE / ORAL | 120 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | POWDER, FOR SUSPENSION / ORAL | 200 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | POWDER / ORAL | 244 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | DROPS / OPHTHALMIC | NA | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, EXTENDED RELEASE / ORAL | 864 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | CAPSULE / ORAL | 0.87 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION / TOPICAL | 6 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | LOTION / TOPICAL | 0.05 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | MOUTHWASH / BUCCAL | 0.15 mg/1ml | ||
| Menthol | MENTHOL | L7T10EIP3A | GEL / TOPICAL | 0.1 %w/w | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | SOLUTION / TOPICAL | 200 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, CHEWABLE / ORAL | 10 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, ORALLY DISINTEGRATING / ORAL | 4 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION / ORAL | 3 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GRANULE / ORAL | 13 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SYRUP / ORAL | 7.5 mg/5ml | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GEL / TOPICAL | 222 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, COATED / ORAL | 13.6 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | SOLUTION / DENTAL | NA | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET / SUBLINGUAL | 2 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / SUBLINGUAL | 1 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET / ORAL | 0.58 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | CONCENTRATE / ORAL | 0.05 mg/5ml | ||
| Menthol | MENTHOL | L7T10EIP3A | SOAP / TOPICAL | 0.75 %w/w | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, DELAYED RELEASE / ORAL | 150 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | FILM, EXTENDED RELEASE / TRANSDERMAL | 19 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET / ORAL | 230 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, COATED PELLETS / ORAL | 41.4 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | LOTION, AUGMENTED / TOPICAL | 0.2 %w/w | ||
| Menthol | MENTHOL | L7T10EIP3A | INHALANT / NASAL | 32 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GRANULE, FOR SUSPENSION / ORAL | 194 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | CAPSULE, EXTENDED RELEASE / ORAL | 204 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | FILM / BUCCAL | 87 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | TABLET, ORALLY DISINTEGRATING / ORAL | 14 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | GEL / TRANSDERMAL | 20 mg | ||
| Hydroxypropyl Cellulose | HYDROXYPROPYL CELLULOSE (1600000 WAMW) | RFW2ET671P | TABLET, DELAYED RELEASE / ORAL | 450 mg | ||
| Menthol | MENTHOL | L7T10EIP3A | JELLY / NASAL | 32.5 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 51f1bb6c-50b6-425e-b536-55c8c693f0fb | c670b97e-98cc-4558-998e-039be5ffd509 | 2011-08-17 | Warnings | 51f1bb6c-50b6-425e-b536-55c8c693f0fb c670b97e-98cc-4558-998e-039be5ffd509 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.